The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
Open accessAbstract
// Navid Koleini 1,2 and Elissavet Kardami 1,2,3 1 Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, Manitoba, Canada 2 Department of Physiology and Pathophysiology, Winnipeg, Manitoba, Canada 3 Department of Human Anatomy and Cell Sciences, University of Manitoba, Winnipeg, Manitoba, Canada Correspondence to: Elissavet Kardami, email: // Keywords : oncocardiology, anthracyclines, heart failure, impaired autophagy and mitophagy, lysosomal dysfunction Received : November 25, 2016 Accepted : March 17, 2017 Published : April 07, 2017 Abstract Doxorubicin (Dox) is a cytotoxic drug widely incorporated in various chemotherapy protocols. Severe side effects such as cardiotoxicity, however, limit Dox application. Mechanisms by which Dox promotes cardiac damage and cardiomyocyte cell death have been investigated extensively, but a definitive picture has yet to emerge. Autophagy, regarded generally as a protective mechanism that maintains cell viability by recycling unwanted and damaged cellular constituents, is nevertheless subject to dysregulation having detrimental effects for the cell. Autophagic cell death has been described, and has been proposed to contribute to Dox-cardiotoxicity. Additionally, mitophagy, autophagic removal of damaged mitochondria, is affected by Dox in a manner contributing to toxicity. Here we will review Dox-induced cardiotoxicity and cell death in the broad context of the autophagy and mitophagy processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 3,996 · cited 3×
“Increased accumulation of p62/ SQSTM1, on the other hand, is linked to the inhibition of autophagic flux/clearance [59].”
BackgroundInfluentialDoxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Tacar, O., Sriamornsak, P., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01567.x · Cited by 2,465
Jung, C. H., Ro, S.-H., Cao, J., Otto, N. M., & Kim, D.-H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.017 · Cited by 2,090
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,414
The axonal transport of mitochondria
Saxton, W. M., & Hollenbeck, P. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.053850 · Cited by 1,185
Autophagy—a key player in cellular and body metabolism
Kim, K. H., & Lee, M.-S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.35 · Cited by 963
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 878
Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 769
Autophagy regulation by nutrient signaling
Russell, R. C., Yuan, H.-X., & Guan, K.-L. (2014) · Cell Research · doi:10.1038/cr.2013.166 · Cited by 710
Sun, N., Yun, J., Liu, J., Malide, D., Liu, C., Rovira, I. I., Holmström, K. M., Fergusson, M. M., Yoo, Y. H., Combs, C. A., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.009 · Cited by 692
Selective autophagy: ubiquitin-mediated recognition and beyond
Kraft, C., Peter, M., & Hofmann, K. (2010) · Nature Cell Biology · doi:10.1038/ncb0910-836 · Cited by 639
The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR
Egan, D., Kim, J., Shaw, R. J., & Guan, K.-L. (2011) · Autophagy · doi:10.4161/auto.7.6.15123 · Cited by 627
Lyu, Y. L., Kerrigan, J. E., Lin, C.-P., Azarova, A. M., Tsai, Y.-C., Ban, Y., & Liu, L. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1649 · Cited by 612
Crosstalk between components of circadian and metabolic cycles in mammals
Asher, G., & Schibler, U. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.006 · Cited by 601
Mitochondrial Control of Cellular Life, Stress, and Death
Galluzzi, L., Kepp, O., Trojel-Hansen, C., & Kroemer, G. (2012) · Circulation Research · doi:10.1161/circresaha.112.268946 · Cited by 545
Hoshino, A., Mita, Y., Okawa, Y., Ariyoshi, M., Iwai-Kanai, E., Ueyama, T., Ikeda, K., Ogata, T., & Matoba, S. (2013) · Nature Communications · doi:10.1038/ncomms3308 · Cited by 536
Zhu, Y., Massen, S., Terenzio, M., Lang, V., Chen-Lindner, S., Eils, R., Novak, I., Dikic, I., Hamacher-Brady, A., & Brady, N. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.399345 · Cited by 488
Image-based genome-wide siRNA screen identifies selective autophagy factors
Orvedahl, A., Sumpter, R., Xiao, G., Ng, A., Zou, Z., Tang, Y., Narimatsu, M., Gilpin, C., Sun, Q., Roth, M., et al. (2011) · Nature · doi:10.1038/nature10546 · Cited by 474
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification
Li, D. L., Wang, Z. V., Ding, G., Tan, W., Luo, X., Criollo, A., Xie, M., Jiang, N., May, H., Kyrychenko, V., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017443 · Cited by 464
Lipshultz, S. E., Scully, R. E., Lipsitz, S. R., Sallan, S. E., Silverman, L. B., Miller, T. L., Barry, E. V., Asselin, B. L., Athale, U., Clavell, L. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70204-7 · Cited by 446
Aging and Autophagy in the Heart
Shirakabe, A., Ikeda, Y., Sciarretta, S., Zablocki, D. K., & Sadoshima, J. (2016) · Circulation Research · doi:10.1161/circresaha.116.307474 · Cited by 441
Lee, Y., Lee, H.-Y., Hanna, R. A., & Gustafsson, Å. B. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00368.2011 · Cited by 397
Hamacher-Brady, A., & Brady, N. R. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2087-8 · Cited by 397
Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Zhang, Y.-W., Shi, J., Li, Y.-J., & Wei, L. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0051-8 · Cited by 387
Mukhopadhyay, P., Rajesh, M., Bátkai, S., Kashiwaya, Y., Haskó, G., Liaudet, L., Szabó, C., & Pacher, P. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2008 · Cited by 376
Lipshultz, S. E., Miller, T. L., Scully, R. E., Lipsitz, S. R., Rifai, N., Silverman, L. B., Colan, S. D., Neuberg, D. S., Dahlberg, S. E., Henkel, J. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.3404 · Cited by 323
Molecular Mechanisms of Mitochondrial Autophagy/Mitophagy in the Heart
Saito, T., & Sadoshima, J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303790 · Cited by 322
Rafiyath, S. M., Rasul, M., Lee, B., Wei, G., Lamba, G., & Liu, D. (2012) · Experimental Hematology & Oncology · doi:10.1186/2162-3619-1-10 · Cited by 302
Topoisomerase levels determine chemotherapy response in vitro and in vivo
Burgess, D. J., Doles, J., Zender, L., Xue, W., Ma, B., McCombie, W. R., Hannon, G. J., Lowe, S. W., & Hemann, M. T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803513105 · Cited by 300
Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
Angsutararux, P., Luanpitpong, S., & Issaragrisil, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/795602 · Cited by 288
AMPK: energy sensor and survival mechanism in the ischemic heart
Qi, D., & Young, L. H. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.010 · Cited by 287
Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death
Kobayashi, S., Volden, P., Timm, D., Mao, K., Xu, X., & Liang, Q. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070037 · Cited by 284
Autophagy in cardiac myocyte homeostasis, aging, and pathology
TERMAN, A., & BRUNK, U. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.014 · Cited by 266
Functional binding of cardiolipin to cytochromec oxidase
Robinson, N. C. (1993) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00762857 · Cited by 265
Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
Damiani, R. M., Moura, D. J., Viau, C. M., Caceres, R. A., Henriques, J. A. P., & Saffi, J. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1759-y · Cited by 247
Autophagy signal transduction by ATG proteins: from hierarchies to networks
Wesselborg, S., & Stork, B. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2034-8 · Cited by 229
Zhu, W., Soonpaa, M. H., Chen, H., Shen, W., Payne, R. M., Liechty, E. A., Caldwell, R. L., Shou, W., & Field, L. J. (2009) · Circulation · doi:10.1161/circulationaha.108.799700 · Cited by 229
Maejima, Y., Adachi, S., Ito, H., Hirao, K., & Isobe, M. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2007.00358.x · Cited by 224
Press, M. F., Sauter, G., Buyse, M., Bernstein, L., Guzman, R., Santiago, A., Villalobos, I. E., Eiermann, W., Pienkowski, T., Martin, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5644 · Cited by 219
Dhingra, R., Margulets, V., Chowdhury, S. R., Thliveris, J., Jassal, D., Fernyhough, P., Dorn, G. W., & Kirshenbaum, L. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414665111 · Cited by 217
Interdependence of Parkin-Mediated Mitophagy and Mitochondrial Fission in Adult Mouse Hearts
Song, M., Gong, G., Burelle, Y., Gustafsson, Å. B., Kitsis, R. N., Matkovich, S. J., & Dorn, G. W. (2015) · Circulation Research · doi:10.1161/circresaha.117.306859 · Cited by 209
Beclin-1: Autophagic regulator and therapeutic target in cancer
Fu, L.-L., Cheng, Y., & Liu, B. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.007 · Cited by 199
Wang, X., Wang, X.-L., Chen, H.-L., Wu, D., Chen, J.-X., Wang, X.-X., Li, R.-L., He, J.-H., Mo, L., Cen, X., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.040 · Cited by 183
Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction
Li, S., Wang, W., Niu, T., Wang, H., Li, B., Shao, L., Lai, Y., Li, H., Janicki, J. S., Wang, X. L., et al. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/748524 · Cited by 183
Cadete, V. J. J., Deschênes, S., Cuillerier, A., Brisebois, F., Sugiura, A., Vincent, A., Turnbull, D., Picard, M., McBride, H. M., & Burelle, Y. (2016) · The Journal of Physiology · doi:10.1113/jp272703 · Cited by 179
Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both Topoisomerase II isoforms
Deng, S., Yan, T., Jendrny, C., Nemecek, A., Vincetic, M., Gödtel-Armbrust, U., & Wojnowski, L. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-842 · Cited by 176
Lu, L., Wu, W., Yan, J., Li, X., Yu, H., & Yu, X. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.01.043 · Cited by 175
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
Lipshultz, S. E., Miller, T. L., Lipsitz, S. R., Neuberg, D. S., Dahlberg, S. E., Colan, S. D., Silverman, L. B., Henkel, J. M., Franco, V. I., Cushman, L. L., et al. (2012) · Pediatrics · doi:10.1542/peds.2012-0727 · Cited by 175
Yoshida, M., Shiojima, I., Ikeda, H., & Komuro, I. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.07.024 · Cited by 174
Cheung, K. G., Cole, L. K., Xiang, B., Chen, K., Ma, X., Myal, Y., Hatch, G. M., Tong, Q., & Dolinsky, V. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.607960 · Cited by 174
Kawaguchi, T., Takemura, G., Kanamori, H., Takeyama, T., Watanabe, T., Morishita, K., Ogino, A., Tsujimoto, A., Goto, K., Maruyama, R., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs282 · Cited by 172
Heme oxygenase-1 regulates mitochondrial quality control in the heart
Hull, T. D., Boddu, R., Guo, L., Tisher, C. C., Traylor, A. M., Patel, B., Joseph, R., Prabhu, S. D., Suliman, H. B., Piantadosi, C. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85817 · Cited by 168
Neilan, T. G., Blake, S. L., Ichinose, F., Raher, M. J., Buys, E. S., Jassal, D. S., Furutani, E., Perez-Sanz, T. M., Graveline, A., Janssens, S. P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.652339 · Cited by 167
Xing, M., Yan, F., Yu, S., & Shen, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133569 · Cited by 157
Xu, X., Chen, K., Kobayashi, S., Timm, D. J., & Liang, Q. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189589 · Cited by 143
Chemical, Biological and Clinical Aspects of Dexrazoxane and Other Bisdioxopiperazines
Hasinoff, B. B., Hellmann, K., Herman, E., & Ferrans, V. J. (1998) · Current Medicinal Chemistry · doi:10.2174/0929867305666220314194045 · Cited by 141
Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity
Sishi, B., Loos, B., van Rooyen, J., & Engelbrecht, A. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.10.005 · Cited by 139
Bartlett, J. J., Trivedi, P. C., Yeung, P. K. F., Kienesberger, P. C., & Pulinilkunnil, T. (2016) · Biochemical Journal · doi:10.1042/bcj20160385 · Cited by 139
Jones, S. E., Collea, R., Paul, D., SEDLACEK, S. M., Favret, A. M., Gore, I., Lindquist, D. L., Holmes, F. A., Allison, M. A. K., Brooks, B. D., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70384-x · Cited by 136
Gharanei, M., Hussain, A., Janneh, O., & Maddock, H. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077713 · Cited by 136
Molecular and cellular basis of lysosomal transmembrane protein dysfunction
Ruivo, R., Anne, C., Sagné, C., & Gasnier, B. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.12.008 · Cited by 134
Pointon, A., Walker, T. M., Phillips, K. M., Luo, J., Riley, J., Zhang, S., Parry, J. D., Lyon, J. J., Marczylo, E. L., & Gant, T. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012733 · Cited by 133
Kobashigawa, L. C., Xu, Y. C., Padbury, J. F., Tseng, Y., & Yano, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104888 · Cited by 127
Lv, X., Yu, X., Wang, Y., Wang, F., Li, H., Wang, Y., Lu, D., Qi, R., & Wang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047351 · Cited by 127
Gratia, S., Kay, L., Potenza, L., Seffouh, A., Novel-Chaté, V., Schnebelen, C., Sestili, P., Schlattner, U., & Tokarska-Schlattner, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs134 · Cited by 125
Roca-Alonso, L., Castellano, L., Mills, A. M., Dabrowska, A. F., Sikkel, M. B., Pellegrino, L., Jacob, J., Frampton, A. E., Krell, J., Coombes, R. C., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.89 · Cited by 123
Chen, M., Wu, X., Gu, J., Guo, Q.-T., Shen, W., & Lu, P. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9153-0 · Cited by 116
Sun, A., Cheng, Y., Zhang, Y., Zhang, Q., Wang, S., Tian, S., Zou, Y., Hu, K., Ren, J. T., & Ge, J. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.01.002 · Cited by 115
Mending a broken heart: the role of mitophagy in cardioprotection
Moyzis, A. G., Sadoshima, J., & Gustafsson, Å. B. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00708.2014 · Cited by 115
Wang, S., Song, P., & Zou, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315812 · Cited by 113
BCL2L13 is a mammalian homolog of the yeast mitophagy receptor Atg32
Otsu, K., Murakawa, T., & Yamaguchi, O. (2015) · Autophagy · doi:10.1080/15548627.2015.1084459 · Cited by 112
Andreadou, I., Mikros, E., Ioannidis, K., Sigala, F., Naka, K. Κ., Kostidis, S., Farmakis, D. T., Τέντα, Ρ., Kavantzas, N., Bibli, S., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.01.007 · Cited by 112
Parker, M. A., King, V., & Howard, K. P. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00371-6 · Cited by 107
Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model
Desai, V. G., Herman, E. H., Moland, C. L., Branham, W. S., Lewis, S. M., Davis, K. J., George, N. I., Lee, T., Kerr, S., & Fuscoe, J. C. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.10.025 · Cited by 105
Dutta, D., Xu, J., Dirain, M. L. S., & Leeuwenburgh, C. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.011 · Cited by 99
Zhang, Y., Zhao, J., Li, R., Lau, W. B., Yuan, Y.-X., Liang, B., Li, R., Gao, E.-H., Koch, W. J., Ma, X.-L., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00577.2014 · Cited by 97
Konishi, M., Haraguchi, G., Ohigashi, H., Ishihara, T., Saito, K., Nakano, Y., & Isobe, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq335 · Cited by 97
Parkin-dependent mitophagy in the heart
Dorn, G. W. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.023 · Cited by 95
ULK1 targets Beclin-1 in autophagy
Nazarko, V. Y., & Zhong, Q. (2013) · Nature Cell Biology · doi:10.1038/ncb2797 · Cited by 89
Zhang, Y., Meng, C., Zhang, X.-M., Yuan, C., Wen, M.-D., Chen, Z., Dong, D., Gao, Y., Liu, C., & Zhang, Z. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.219261 · Cited by 87
p53 Mediates Autophagy and Cell Death by a Mechanism Contingent On Bnip3
Wang, E. Y., Gang, H., Aviv, Y., Dhingra, R., Margulets, V., & Kirshenbaum, L. A. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01028 · Cited by 86
Yamaguchi, O., Murakawa, T., Nishida, K., & Otsu, K. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.03.010 · Cited by 86
Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity
Gu, J. F., Hu, W. G., Song, Z., Chen, Y., Zhang, D., & Wang, C. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.002 · Cited by 85
Cardiac Toxicity of Anticancer Agents
Colombo, A., Cipolla, C. M., Beggiato, M., & Cardinale, D. M. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0362-6 · Cited by 84
Macrophage Migration Inhibitory Factor Deficiency Augments Doxorubicin‐Induced Cardiomyopathy
Xu, X., Bucala, R., & Ren, J. T. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000439 · Cited by 82
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins
Bian, Y., Sun, M., Silver, M., Ho, K. K. L., Marchionni, M. A., Caggiano, A. O., Stone, J. R., Amende, I., Hampton, T., Morgan, J. P., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01010.2008 · Cited by 82
Jirkovská, A., Jansová, H., Macková, E., Macháček, M., Hašková, P., Tichotová, L., Štěrba, M., & Šimůnek, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076676 · Cited by 76
Dimitrakis, P., Romay-Ogando, M.-I., Timolati, F., Suter, T. M., & Zuppinger, C. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1475-8 · Cited by 75
Concomitant low-dose doxorubicin treatment and exercise
Sturgeon, K. M., Schadler, K., Muthukumaran, G., Ding, D., Bajulaiye, A., Thomas, N. J., Ferrari, V. A., Ryeom, S. W., & Libonati, J. R. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00082.2014 · Cited by 75
Mitochondrial autophagy in cardiomyopathy
Tong, M., & Sadoshima, J. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.02.006 · Cited by 75
Velez, J. M., Miriyala, S., Nithipongvanitch, R., Noel, T. J., Plabplueng, C. D., Oberley, T. D., Jungsuwadee, P., Remmen, H. V., Vore, M. E., & Clair, D. K. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018005 · Cited by 73
Xu, X., Pang, J., Chen, Y., Bucala, R., Zhang, Y., & Ren, J. T. (2016) · Scientific Reports · doi:10.1038/srep22488 · Cited by 73
Srisakuldee, W., Makazan, Z., Nickel, B. E., Zhang, F., Thliveris, J. A., Pasumarthi, K. B. S., & Kardami, E. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu066 · Cited by 71
Self-citationLuo, R., Li, Y., He, M., Zhang, H., Yuan, H., Johnson, M. T., Palmisano, M., Zhou, S. Y., & Sun, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.002 · Cited by 69
Chen, K., Xu, X., Kobayashi, S., Timm, D. J., Jepperson, T. N., & Liang, Q. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225805 · Cited by 68
Tumor Necrosis Factor Receptor–Associated Factor 2 Mediates Mitochondrial Autophagy
Yang, K., Ma, X., Liu, H., Murphy, J. T., Barger, P. M., Mann, D. L., & Diwan, A. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001635 · Cited by 66
Doxorubicin toxicity changes myocardial energy metabolism in rats
Wu, R., Wang, H., Yu, H., Cui, X., Xu, M.-T., Xu, X., & Gao, J. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.12.010 · Cited by 62
Dickey, J. S., Gonzalez, Y., Aryal, B., Mog, S., Nakamura, A. J., Redon, C. E., Baxa, U., Rosen, E., Cheng, G., Zielonka, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070575 · Cited by 60
Feridooni, T., Hotchkiss, A. G., Remley-Carr, S., Saga, Y., & Pasumarthi, K. B. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022801 · Cited by 57
P53 inhibition exacerbates late-stage anthracycline cardiotoxicity
Zhu, W., Zhang, W., Shou, W., & Field, L. J. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu118 · Cited by 57
Nordgren, K. K. S., & Wallace, K. B. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.023 · Cited by 54
Singla, D. K. (2014) · Cell Transplantation · doi:10.3727/096368914x679200 · Cited by 53
Mitra, M. S., Donthamsetty, S., White, B., Latendresse, J. R., & Mehendale, H. M. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.07.018 · Cited by 51
Lee, B. S., Oh, J., Kang, S. K., Park, S., Lee, S., Choi, D., Chung, J. H., Chung, Y. W., & Kang, S.-M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135438 · Cited by 51
Doxorubicin induces protein ubiquitination and inhibits proteasome activity during cardiotoxicity
Sishi, B., Loos, B., van Rooyen, J., & Engelbrecht, A. (2013) · Toxicology · doi:10.1016/j.tox.2013.04.016 · Cited by 49
Effects of doxorubicin on cardiac muscle subsarcolemmal and intermyofibrillar mitochondria
Kavazis, A. N., Morton, A. B., Hall, S. E., & Smuder, A. J. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.10.008 · Cited by 49
Mechanism of anthracycline-mediated down-regulation of GATA4 in the heart
Park, A.-M., Nagase, H., Liu, L., Kumar, S. V., Szwergold, N. R., Wong, C., & Suzuki, Y. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq361 · Cited by 47
Tokarska-Schlattner, M., Lucchinetti, E., Zaugg, M., Kay, L., Gratia, S., Guzun, R., Saks, V. A., & Schlattner, U. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00360.2009 · Cited by 46
Gao, S., Li, H., Feng, X., Li, M., Liu, Z., Cai, Y., Lü, J., Huang, X., Wang, J., Li, Q., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.11.007 · Cited by 45
Identification of the site of adriamycin-activation in the heart cell
Nohl, H. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90257-2 · Cited by 43
Zhang, C., Liao, Y., Li, Q., Chen, M., Zhao, Q., Deng, R., Wu, C., Yang, A., Guo, Z., Wang, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066382 · Cited by 42
Chang, Y., Lee, H., Liu, S.-T., Lin, Y., Chen, T., Hsieh, T., Huang, H., & Huang, S.-M. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.08.006 · Cited by 31
Autophagy in the Heart: Too Much of a Good Thing?
Wang, E. Y., Biala, A. K., Gordon, J. W., & Kirshenbaum, L. A. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31824cc427 · Cited by 27
Gréen, H., Stål, O., Bachmeier, K., Bäcklund, L. M., Carlsson, L. M. S., Hansen, J., Lagerlund, M., Norberg, B., Franzén, Å., Åleskog, A., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.017 · Cited by 25
Hong, E., Kim, B. W., Jung, D. Y., Kim, J. H., Yu, T. Y., da‐Silva, W. S., Friedline, R. H., Bianco, S. D. C., Seslar, S. P., Wakimoto, H., et al. (2013) · Endocrinology · doi:10.1210/en.2012-2261 · Cited by 24
Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart
Sishi, B., Bester, D. J., Wergeland, A., Loos, B., Jonassen, A. K., van Rooyen, J., & Engelbrecht, A. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011106 · Cited by 20
da Silva, M. G., Mattos, E. C., Camacho-Pereira, J., et al. (2012) · PubMed · Cited by 7
Cited by
Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111708 · Cited by 909
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
Wallace, K. B., Sardão, V. A., & Oliveira, P. J. (2020) · Circulation Research · doi:10.1161/circresaha.119.314681 · Cited by 599
Kalyanaraman, B. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101394 · Cited by 326
Parama, D., Boruah, M., Yachna, K., Rana, V., Banik, K., Harsha, C., Thakur, K. K., Dutta, U., Arya, A., Mao, X., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118182 · Cited by 155
Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection
Kura, B., Kalocayova, B., Devaux, Y., & Bartekova, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030700 · Cited by 106
Metadata
- Authors
- Koleini, N., & Kardami, E.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-04-07
- Volume
- 8
- Issue
- 28
- Pages
- 46663-46680
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2604294853
- Cited by
- 301
- References
- 122
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.